MiR-204-5p Alleviates Neuropathic Pain by Targeting BRD4 in a Rat Chronic Constrictive Injury Model
Xiaona Guo,Xia Geng,Yunchao Chu,Jianfei Gao,Linkai Jiang
DOI: https://doi.org/10.2147/JPR.S371616
IF: 2.8319
2022-08-18
Journal of Pain Research
Abstract:Xiaona Guo, 1, &ast Xia Geng, 1, &ast Yunchao Chu, 2 Jianfei Gao, 1 Linkai Jiang 1 1 Pain Department, Dongying People's Hospital, Dongying, Shandong, People's Republic of China; 2 Pain Department, Shengli Oilfield Central Hospital, Dongying, Shandong, People's Republic of China &astThese authors contributed equally to this work Correspondence: Linkai Jiang, Pain Department, Dongying People's Hospital, No. 317, Dongcheng Nanyi Road, Dongying, Shandong, 257091, People's Republic of China, Tel +86 546-8901234, Email Purpose: The pathogenesis of neuropathic pain is complex, and previous studies have found that microRNAs are important regulators of neuropathic pain and are associated with the progression of neuropathic pain. This study aims to explore the level and role of miR-204-5p in the chronic constrictive injury (CCI) model of rats. Patients and Methods: The CCI rat model was constructed to evaluate paw withdrawal threshold (PWT), paw withdrawal latency (PWL), the expressions of miR-204-5p, and the contents of inflammatory factors in the model. Overexpression of miR-204-5p in rat spinal cord was induced by intrathecal injection of miR-204-5p mimics. PWT and PWL were used to estimate mechanical and thermal pain thresholds. IL-6 and TNF-α were determined by ELISA. Luciferase reporter gene was conducted to verify the targeting relationship between miR-204-5p and BRD4. Results: miR-204-5p was abnormally down-regulated in the CCI group. The thresholds of mechanical and thermal pain stimulation in the CCI group were lower, and the levels of inflammatory factors were higher than those in the sham group. Overexpression of miR-204-5p alleviated PWT, PWL and inflammatory factors. Besides, the luciferase reporter gene showed that BRD4 was a target gene of miR-204-5p. Conclusion: These results suggested that miR-204-5p may alleviate neuropathic pain and inflammation through targeted regulation of BRD4 expression. Keywords: neuropathic pain, miR-204-5p, chronic constrictive injury model, BRD4 Neuropathic pain is a nervous system disease caused by primary pathological changes or dysfunction of central or peripheral nervous system, which is characterized by allodynia and hyperalgesia of somatosensory system. 1,2 Infection, trauma, ischemia, inflammation and other factors can cause central and peripheral nerve damage, resulting in neuropathic pain. 3 Neuropathic pain has become a global problem, affecting about 7% to 10% of the world's population and incurring enormous socioeconomic costs. 4 At present, neuropathic pain is a complex disease whose mechanism is still unclear. Therefore, a more accurate understanding of the molecular mechanisms underlying the pathogenesis of neuropathic pain is crucial for finding new and effective therapeutic targets. MicroRNAs (miRNAs) are a new class of non-coding RNAs with about 22 nucleotides, and they can bind to the 3'-UTR of multiple mRNA targets. 5,6 Today, miRNAs have been established as key micro-regulators of normal cellular homeostasis, and similarly, dysregulation of miRNA is associated with cancer, cardiovascular disease, inflammatory diseases, and neurodegenerative diseases. 7 In the past few decades, the research of miRNA related to somatic pain has been developing rapidly, several studies have confirmed that neurological diseases can induce changes in miRNA expression profile. It was found that mouse sciatic nerve injury resulted in the down-regulation of miR-200b in postsynaptic neurons, which was closely related to the increase of DNMT3a. 8 Another study analyzed hippocampal formation in CCI rats using the TaqMan low-density array, with 51 miRNA expressions significantly altered compared to contralateral sham surgery. 9 MiR-204-5p was located in intron 6 of TRPM3 and was originally found to be abnormally expressed in melanoma. 10 A study reported that miR-204-5p expression changes have been found in patients with neuropathic pain caused by spinal cord injury and is expected to be a potential marker of SCI. 11 And another study has also been reported that miR-204 is abnormally expressed in rat spinal cord compression (SCC) model. 12 However, at present, few studies have focused on analyzing the mechanism of miR-204-5p regulating the neuropathic pain. Furthermore, the miRNA.org database has predicted the relationship between miR-204-5p and bromodomain-containing protein 4 (BRD4). A previous study showed that BRD4 is associated with neuropathic pain. BRD4 has been reported to be involved in the regulation of various pathophysiological activities, such as inflammation and o -Abstract Truncated-
clinical neurology